BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37087403)

  • 1. [Prognostic factors for non-small cell lung cancer patients with central nervous system metastasis with positive driver genes].
    Li R; Zhang SR; Liu XF; Zhang JW; Zhao JY; Bai P; Zhang XC
    Zhonghua Yi Xue Za Zhi; 2023 Apr; 103(16):1202-1209. PubMed ID: 37087403
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of Recursive Partitioning Analysis and Graded Prognostic Assessment on Identifying Non-Small Cell Lung Cancer Patients with Brain Metastases Who May Benefit from Postradiation Systemic Therapy.
    Liu S; Chen P; Liu YW; Gu XN; Qiu XG; Li B
    Chin Med J (Engl); 2018 May; 131(10):1206-1213. PubMed ID: 29722340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Factors and Survival Benefits of Antitumor Treatments for Advanced Non-Small Cell Lung Cancer Patients With Central Nervous System Metastasis With or Without Driver Genes: A Chinese Single-Center Cohort Study.
    Gao X; Chen M; Liu X; Shi Y; Liang H; Zhou Q; Zhao J; Pan R; Zhong W; Xu Y; Wang M
    Front Oncol; 2022; 12():879554. PubMed ID: 35558520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applicability of the lung-molGPA index in non-small cell lung cancer patients with different gene alterations and brain metastases.
    Chen K; Yu X; Zhang F; Xu Y; Zhang P; Huang Z; Fan Y
    Lung Cancer; 2018 Nov; 125():8-13. PubMed ID: 30429042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of quality of life and survival following Gamma Knife surgery for lung cancer brain metastases: a prospective study.
    Bragstad S; Flatebø M; Natvig GK; Eide GE; Skeie GO; Behbahani M; Pedersen PH; Enger PØ; Skeie BS
    J Neurosurg; 2018 Jul; 129(1):71-83. PubMed ID: 28820304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Real-world study on the efficacy and prognostic predictive biomarker of patients with metastatic non-small cell lung cancer treated with programmed death-1/programmed death ligand 1 inhibitors].
    Zhu WJ; Zhu HH; Liu YT; Lin L; Xing PY; Hao XZ; Cong MH; Wang HY; Wang Y; Li JL; Feng Y; Hu XS
    Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):416-424. PubMed ID: 35615798
    [No Abstract]   [Full Text] [Related]  

  • 7. Assessment of prognostic scores of brain metastases from lung adenocarcinoma with EGFR mutations.
    Li H; Lian J; Jin H; Wang W; Cao J; Zhang X; Song X; Jia S; Jia H; Ren J; Han S; Yang W; Xi Y; Lan S
    J Neurooncol; 2017 May; 133(1):129-135. PubMed ID: 28391386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Driver genes as predictive indicators of brain metastasis in patients with advanced NSCLC: EGFR, ALK, and RET gene mutations.
    Wang H; Wang Z; Zhang G; Zhang M; Zhang X; Li H; Zheng X; Ma Z
    Cancer Med; 2020 Jan; 9(2):487-495. PubMed ID: 31769228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of prognostic nutritional index (PNI) and neutrophil to lymphocyte ratio (NLR) for advanced non-small cell lung cancer treated with platinum-based chemotherapeutics.
    Wang J; Liu Y; Mi X; Shao M; Liu L
    Ann Palliat Med; 2020 May; 9(3):967-978. PubMed ID: 32389020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA).
    Sperduto PW; Yang TJ; Beal K; Pan H; Brown PD; Bangdiwala A; Shanley R; Yeh N; Gaspar LE; Braunstein S; Sneed P; Boyle J; Kirkpatrick JP; Mak KS; Shih HA; Engelman A; Roberge D; Arvold ND; Alexander B; Awad MM; Contessa J; Chiang V; Hardie J; Ma D; Lou E; Sperduto W; Mehta MP
    JAMA Oncol; 2017 Jun; 3(6):827-831. PubMed ID: 27892978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local tumor response and survival outcomes after combined stereotactic radiosurgery and immunotherapy in non-small cell lung cancer with brain metastases.
    Singh C; Qian JM; Yu JB; Chiang VL
    J Neurosurg; 2019 Feb; 132(2):512-517. PubMed ID: 30771783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recursive partitioning analysis classification and graded prognostic assessment for non-small cell lung cancer patients with brain metastasis: a retrospective cohort study.
    Sun CX; Li T; Zheng X; Cai JF; Meng XL; Yang HJ; Wang Z
    Chin J Cancer Res; 2011 Sep; 23(3):177-82. PubMed ID: 23467694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of Recursive Partitioning Analysis and Diagnosis-Specific Graded Prognostic Assessment in patients treated initially with radiosurgery alone.
    Likhacheva A; Pinnix CC; Parikh N; Allen PK; Guha-Thakurta N; McAleer M; Sulman EP; Mahajan A; Shiu A; Luo D; Chiu M; Brown PD; Prabhu SS; Chang EL
    J Neurosurg; 2012 Dec; 117 Suppl(0):38-44. PubMed ID: 23205787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New prognostic system specific for epidermal growth factor receptor-mutated lung cancer brain metastasis.
    Zhu LH; Fan XW; Sun L; Ni TT; Li YQ; Wu CY; Wu KL
    Front Oncol; 2023; 13():1093084. PubMed ID: 37020869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Value of the Systemic Immune-Inflammation Index in Predicting Survival Outcomes in Patients with Brain Metastases of Non-Small-Cell Lung Cancer Treated with Stereotactic Radiotherapy.
    Zhang Y; Chen Z; Jin F; Guo D; Chen Q; Liu Z; Ji S; Gao G
    Mediators Inflamm; 2021; 2021():2910892. PubMed ID: 34744510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management and Outcomes of Newly Diagnosed Non-Small Cell Lung Cancer Patients with Brain Metastases: A Real-World Study in Japan.
    Yoshida H; Kim YH; Iwatsubo S; Sakaguchi C; Sakamori Y; Nagai H; Ozasa H; Mio T; Hirai T
    Oncology; 2020; 98(7):460-467. PubMed ID: 32222702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors and outcome of surgically treated patients with brain metastases of non-small cell lung cancer.
    She C; Wang R; Lu C; Sun Z; Li P; Yin Q; Liu Q; Wang P; Li W
    Thorac Cancer; 2019 Feb; 10(2):137-142. PubMed ID: 30485664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic indices in stereotactic radiotherapy of brain metastases of non-small cell lung cancer.
    Kaul D; Angelidis A; Budach V; Ghadjar P; Kufeld M; Badakhshi H
    Radiat Oncol; 2015 Nov; 10():244. PubMed ID: 26611493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Prognostic Indices in NSCLC Patients with Brain Metastases after Radiosurgery.
    Gao HX; Huang SG; Du JF; Zhang XC; Jiang N; Kang WX; Mao J; Zhao Q
    Int J Biol Sci; 2018; 14(14):2065-2072. PubMed ID: 30585269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy.
    Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hoerner-Rieber J; König L; Kappes J; Thomas M; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
    J Neurooncol; 2017 Aug; 134(1):205-212. PubMed ID: 28560661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.